Press "Enter" to skip to content

FDA orders important safety labeling changes for Addyi

FDA has issued a safety labeling change order to Sprout Pharmaceuticals for their drug, Addyi requiring the company to revise important safety information.

Also Read:   FDA Provides Guidance to Industry for Detecting and Preventing Nitrosamines in Drugs